Responses
FRIDAY, 15 JUNE 2018
Rheumatoid arthritis – biological DMARDs
FRI0127 Open-label non-mandatory transitioning from originator etanercept to biosimilar sb4: 6-month results from a controlled cohort study
Compose a Response to This Article
Other responses
No responses have been published for this article.